Kesharwani / Thakur | Cancer Epigenetics and Nanomedicine | Buch | 978-0-443-13209-4 | sack.de

Buch, Englisch, 458 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 950 g

Kesharwani / Thakur

Cancer Epigenetics and Nanomedicine

Targeting the Right Player Via Nanotechnology
Erscheinungsjahr 2024
ISBN: 978-0-443-13209-4
Verlag: Elsevier Science

Targeting the Right Player Via Nanotechnology

Buch, Englisch, 458 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 950 g

ISBN: 978-0-443-13209-4
Verlag: Elsevier Science


Cancer Epigenetics and Nanomedicine: Targeting the Right Player via Nanotechnology is a complete package that provides a comprehensive and thorough understanding of the key players that modulate the various steps of carcinogenesis and malignant progression of the disease and the critical targets to be exploited for developing novel modalities of diagnosis and therapeutics.

Since epigenetic aberrations can be potentially reversed and restored to their normal state through epigenetic therapy, the book also discusses the challenges and the future of the field with the cutting-edge revelations and limitations that this research endeavor can offer, thereby helping the readers to enhance their critical thinking and adopt strategies of therapeutic importance.

Kesharwani / Thakur Cancer Epigenetics and Nanomedicine jetzt bestellen!

Weitere Infos & Material


SECTION 1 Overview of cancer, internal and external factors associated with cancer
1. Overview of cancer: Mechanisms of carcinogenesis
2. Tumor metabolism and micronutrients: New insights to target malignant tumors
3. The role of one-carbon amino acids in tumor-immune metabolism: From oncogenesis to therapy
4. Environmental causes of cancer
5. Cancer stem cells-Challenges for cancer therapies
6. Carving a therapeutic niche for metastatic cancer: Opportunities and challenges

SECTION 2 Epigenetics and its importance in cancer therapies
7. An overview of epigenetics and cancer
8. Metabolic adaptation and epigenetic modulations: Unraveling tumor plasticity under variable tumor microenvironment
9. Involvement of epigenetic modifications in cancer stem cells and chemoresistance
10. Cancer biomarkers: Where genetics meets epigenetics
11. Epigenetics approach in cancer treatment with focus on lung and breast cancer
12. Dietary components as epigenetic modifiers and their roles in cancer prevention

SECTION 3 Nanomedicine targeting epigenetic machinery in cancer therapy
13. Harnessing plant-derived biosynthetic nanomaterials for epigenetic modulation in cancer therapy
14. Nanotechnology-enhanced immunotherapy for cancer
15. Nanoparticles in metastatic cancer treatment
16. Amine-terminated dendrimers: A novel method for diagnose, control and treatment of cancer
17. Nanomedicine and epigenome: Possible health risks, benefits, and future perspectives
18. Smart cancer nanomedicine: Challenges and future opportunities



Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.